here
Access campaign
MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB...
July 17, 2024 | India
Access campaignPress release
As Gavi plans next five-year strategy, it must do more to get vaccines to people...
April 16, 2024 |
Access campaignStatements and Opinions
Switzerland
MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions
February 15, 2024 | IndiaSwitzerland
Access campaignStatements and Opinions
Switzerland
Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as...
February 14, 2024 | IndiaSwitzerland
Access campaignPress release
Landmark clinical trial redefines multidrug-resistant tuberculosis Treatment options
November 15, 2023 | France
Access campaignPress release
MSF warns governments are failing to test, treat and prevent TB in children
November 14, 2023 |
Press release
MSF: TB test price reduction by Cepheid and Danaher is an important step in the...
September 19, 2023 |
Access campaign
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to...
September 12, 2023 |
Access campaign
TB medicine deal offers short-term solution, but J&J needs to do more for all affected...
July 14, 2023 |
